Oxford Asset Management Boosted By $783,900 Its Five Prime Therapeutics (FPRX) Position; Armada Hoffler Properties (AHH) Sentiment Is 2.84

September 6, 2017 - By Henry Gaston

Armada Hoffler Properties, Inc. is a real estate company. The company has market cap of $851.91 million. The Firm is engaged in developing, building, owning and managing institutional-grade office, retail and multifamily properties in various markets throughout the Mid-Atlantic and Southeastern United States. It has a 33.64 P/E ratio. In addition to the ownership of its operating property portfolio, the Company develops and manufactures properties for its own account and through joint ventures between the Company and unaffiliated partners.

Oxford Asset Management increased Five Prime Therapeutics Inc (FPRX) stake by 29.5% reported in 2016Q4 SEC filing. Oxford Asset Management acquired 15,678 shares as Five Prime Therapeutics Inc (FPRX)’s stock declined 39.09%. The Oxford Asset Management holds 68,826 shares with $3.45M value, up from 53,148 last quarter. Five Prime Therapeutics Inc now has $889.77 million valuation. The stock declined 2.80% or $0.92 reaching $32.06 on the news. About 116,130 shares traded. Five Prime Therapeutics Inc (NASDAQ:FPRX) has declined 30.56% since September 6, 2016 and is downtrending. It has underperformed by 47.26% the S&P500.

About 197,843 shares traded. Armada Hoffler Properties Inc (AHH) has risen 9.92% since September 6, 2016 and is uptrending. It has underperformed by 6.78% the S&P500.

Chilton Capital Management Llc holds 1.19% of its portfolio in Armada Hoffler Properties Inc for 779,963 shares. Albert D Mason Inc owns 36,040 shares or 0.46% of their US portfolio. Moreover, Phocas Financial Corp. has 0.38% invested in the company for 400,602 shares. The Virginia-based Wilbanks Smith & Thomas Asset Management Llc has invested 0.29% in the stock. Ativo Capital Management Llc, a Illinois-based fund reported 81,374 shares.

Oxford Asset Management decreased Surgery Partners Inc stake by 24,978 shares to 71,632 valued at $1.14 million in 2016Q4. It also reduced Omega Protein Corp (NYSE:OME) stake by 37,360 shares and now owns 136,643 shares. Alliance Data Systems Corp (NYSE:ADS) was reduced too.

Investors sentiment decreased to 0.7 in 2016 Q4. Its down 0.13, from 0.83 in 2016Q3. It worsened, as 19 investors sold FPRX shares while 69 reduced holdings. 16 funds opened positions while 49 raised stakes. 24.63 million shares or 4.67% less from 25.83 million shares in 2016Q3 were reported. Barclays Public Ltd Co holds 0% or 7,690 shares. Prudential Fincl stated it has 64,786 shares or 0.01% of all its holdings. Tocqueville Asset Mngmt Ltd Partnership invested 0.01% in Five Prime Therapeutics Inc (NASDAQ:FPRX). Dimensional Fund Advisors Ltd Partnership accumulated 841,072 shares or 0.02% of the stock. Clinton Inc stated it has 8,175 shares. Fund Mgmt Sa reported 0.07% of its portfolio in Five Prime Therapeutics Inc (NASDAQ:FPRX). Metropolitan Life Insurance has invested 0.01% of its portfolio in Five Prime Therapeutics Inc (NASDAQ:FPRX). Sg Americas Securities Limited Liability Corp stated it has 3,215 shares or 0% of all its holdings. Swiss Bankshares reported 0% of its portfolio in Five Prime Therapeutics Inc (NASDAQ:FPRX). Hays Advisory Lc reported 1.07% of its portfolio in Five Prime Therapeutics Inc (NASDAQ:FPRX). Gsa Cap Prtn Llp has invested 0.22% in Five Prime Therapeutics Inc (NASDAQ:FPRX). Suntrust Banks accumulated 0% or 4,497 shares. Aqr Cap Mgmt Ltd reported 128,095 shares stake. The New York-based Fred Alger Mgmt has invested 0% in Five Prime Therapeutics Inc (NASDAQ:FPRX). Daiwa Sb Invs has invested 0.08% in Five Prime Therapeutics Inc (NASDAQ:FPRX).